New drug combo aims to outperform standard care in Hard-to-Treat myeloma
Disease control
Ongoing
This study tests a new three-drug combination (selinexor, pomalidomide, and dexamethasone) against another standard combination (elotuzumab, pomalidomide, and dexamethasone) in 117 adults with multiple myeloma that has come back or stopped responding to prior treatments. Particip…
Phase: PHASE3 • Sponsor: European Myeloma Network B.V. • Aim: Disease control
Last updated May 11, 2026 20:38 UTC